Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Meyer

Showing results (481-490 of 510) with videos related to

Pageof 51
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomasTim Meyer, Andrew M Gaya, Gairin Dancey, et al.
Nature Communications|May 15, 2021
Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpointNathalie M Schmidt, Peter A C Wing, Mariana O Diniz, et al.
Liver Cancer|March 6, 2023
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 TrialZhenggang Ren, Michel Ducreux, Ghassan K Abou-Alfa, et al.
Sports Medicine (Auckland, N.Z.)|January 11, 2024
COVID-19 in Female and Male Athletes: Symptoms, Clinical Findings, Outcome, and Prolonged Exercise Intolerance-A Prospective, Observational, Multicenter Cohort Study (CoSmo-S)Manuel Widmann, Roman Gaidai, Isabel Schubert, et al.
JMIR Research Protocols|October 4, 2019
VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver MalignanciesLaura Beaton, Henry F J Tregidgo, Sami A Znati, et al.
Cell Reports. Medicine|August 20, 2025
Rewired type I IFN signaling is linked to age-dependent differences in COVID-19Lev Petrov, Sophia Brumhard, Sebastian Wisniewski, et al.
British Journal of Sports Medicine|October 24, 2020
UEFA expert group statement on nutrition in elite football. Current evidence to inform practical recommendations and guide future researchJames Collins, Ronald John Maughan, Michael Gleeson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with CancerAyumi Hashimoto, Debashis Sarker, Vikash Reebye, et al.
Journal of Hepatology|August 14, 2025
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinomaTim Meyer, Richard S Finn, Mitesh Borad, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 8, 2022
Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver MalignanciesLaura Beaton, Henry F J Tregidgo, Sami A Znati, et al.
Pageof 51

Showing results (481-490 of 510) with videos related to

Sort By:
Pageof 51
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2009
A phase I trial of radioimmunotherapy with 131I-A5B7 anti-CEA antibody in combination with combretastatin-A4-phosphate in advanced gastrointestinal carcinomasTim Meyer, Andrew M Gaya, Gairin Dancey, et al.
Nature Communications|May 15, 2021
Targeting human Acyl-CoA:cholesterol acyltransferase as a dual viral and T cell metabolic checkpointNathalie M Schmidt, Peter A C Wing, Mariana O Diniz, et al.
Liver Cancer|March 6, 2023
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 TrialZhenggang Ren, Michel Ducreux, Ghassan K Abou-Alfa, et al.
Sports Medicine (Auckland, N.Z.)|January 11, 2024
COVID-19 in Female and Male Athletes: Symptoms, Clinical Findings, Outcome, and Prolonged Exercise Intolerance-A Prospective, Observational, Multicenter Cohort Study (CoSmo-S)Manuel Widmann, Roman Gaidai, Isabel Schubert, et al.
JMIR Research Protocols|October 4, 2019
VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver MalignanciesLaura Beaton, Henry F J Tregidgo, Sami A Znati, et al.
Cell Reports. Medicine|August 20, 2025
Rewired type I IFN signaling is linked to age-dependent differences in COVID-19Lev Petrov, Sophia Brumhard, Sebastian Wisniewski, et al.
British Journal of Sports Medicine|October 24, 2020
UEFA expert group statement on nutrition in elite football. Current evidence to inform practical recommendations and guide future researchJames Collins, Ronald John Maughan, Michael Gleeson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2021
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with CancerAyumi Hashimoto, Debashis Sarker, Vikash Reebye, et al.
Journal of Hepatology|August 14, 2025
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinomaTim Meyer, Richard S Finn, Mitesh Borad, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 8, 2022
Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver MalignanciesLaura Beaton, Henry F J Tregidgo, Sami A Znati, et al.
Pageof 51